Joint Rehab and Sport Medical Center - Logo

Medical research and clinical observation has clearly shown that cartilage has poor ability to spontaneously repair itself. Traditional treatments such as microfracture (a surgical option that creates small holes in the bone to allow blood flow to the damaged cartilage area in an attempt to stimulate new cartilage growth), bone drilling and autologous osteochondral graft (cartilage from one area patched into the “hole”) were not fully satisfactory to fulfill the patient needs. This is why medical research centers on regenerative medicine (bone marrow aspirate concentrate injections or sometimes referred to as bone marrow stem cell therapy) as treatments that should be further researched and possibly be considered the future of treatment for degenerative joint disease.

We are proud to have authored numerous research papers and forthcoming research papers on the use of stem cells in regenerative healing. These include the following peer-reviewed studies.

Research in the medical community is focused on how bone marrow stem cells work in rebuilding the damaged part of the body, a knee, a shoulder,  hip, etc., from within by turning a diseased joint environment into a healing joint environment.

Numerous studies support the healing and repair effects of bone marrow stem cells. To be balanced, it should be pointed out that some studies suggest limited or little or no positive impact of treatment.

Bone marrow stem cell – Research studies and reviews

Bone marrow stem cell therapy is the injection, into a damaged joint and surrounding area, of stem cells drawn from the patient’s own bone marrow. Stem cells are “de-differentiated pluripotent” cells, which mean that they continue to divide to create more stem cells; these cells eventually “morph” into the tissue needing repair—for our purposes, collagen, bone, and cartilage.

In the following articles, research into bone marrow stem cell injections are explored:

The use of bone marrow-derived stem cells was first tested in the 1960s. Even then, doctors knew that stem cells had unique regenerative powers due to their ability to morph into bone and cartilage and migrate to the site of damage once introduced into the body. Using stem cells from a patient’s own bone marrow was particularly interesting, because these types of autologous stem cells are readily available from the patient themselves. Some research suggests that the introduction of stem cells into the joint also reawakens and revitalizes the stem cells already present in the synovial fluid, cartilage and bone.

Recent research

A March 2023 paper review study (1) compared the efficacy and safety of platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and hyaluronic acid (HA) injections for the treatment of knee osteoarthritis (OA).

The research team concluded their review by suggesting: “Patients undergoing treatment for knee osteoarthritis with PRP or bone marrow aspirate concentrate can be expected to experience improved clinical outcomes when compared to hyaluronic acid patients.

1 Belk JW, Lim JJ, Keeter C, McCulloch PC, Houck DA, McCarty EC, Frank RM, Kraeutler MJ. Patients With Knee Osteoarthritis Who Receive Platelet-Rich Plasma or Bone-Marrow Aspirate Concentrate Injections Have Better Outcomes Than Patients Who Receive Hyaluronic Acid: Systematic Review and Meta-analysis. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2023 Mar 11.

Skip to content